Quoin Pharmaceuticals, Ltd. (QNRX)
NASDAQ: QNRX · Real-Time Price · USD
12.09
-6.82 (-36.07%)
At close: Dec 5, 2025, 4:00 PM EST
11.45
-0.64 (-5.29%)
After-hours: Dec 5, 2025, 7:43 PM EST
Quoin Pharmaceuticals Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
| Selling, General & Admin | 6.42 | 5.93 | 6.07 | 6.58 | 4.5 | 1.43 | |
| Research & Development | 7.76 | 3.6 | 3.31 | 2.67 | 1.56 | 0.24 | |
| Operating Expenses | 14.18 | 9.53 | 9.38 | 9.26 | 6.06 | 1.67 | |
| Operating Income | -14.18 | -9.53 | -9.38 | -9.26 | -6.06 | -1.67 | |
| Interest Expense | - | - | - | -0.71 | -1.37 | -0.05 | |
| Interest & Investment Income | 0.42 | 0.56 | 0.69 | 0.1 | - | - | |
| Other Non Operating Income (Expenses) | -0.01 | 0.01 | -0 | 0.08 | -12.78 | - | |
| EBT Excluding Unusual Items | -13.77 | -8.96 | -8.69 | -9.8 | -20.21 | -1.72 | |
| Other Unusual Items | - | - | - | 0.42 | -1.25 | -0.38 | |
| Pretax Income | -13.77 | -8.96 | -8.69 | -9.38 | -21.46 | -2.1 | |
| Net Income | -13.77 | -8.96 | -8.69 | -9.38 | -21.46 | -2.1 | |
| Preferred Dividends & Other Adjustments | - | - | - | 0.07 | - | - | |
| Net Income to Common | -13.77 | -8.96 | -8.69 | -9.45 | -21.46 | -2.1 | |
| Shares Outstanding (Basic) | 0 | 0 | 0 | - | - | - | |
| Shares Outstanding (Diluted) | 0 | 0 | 0 | - | - | - | |
| Shares Change (YoY) | 416.87% | 420.43% | - | - | - | - | |
| EPS (Basic) | -28.25 | -66.90 | -337.46 | - | - | - | |
| EPS (Diluted) | -28.39 | -66.90 | -337.46 | - | - | - | |
| EBITDA | -14.08 | -9.43 | -9.27 | -9.15 | -5.96 | -1.57 | |
| D&A For EBITDA | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | |
| EBIT | -14.18 | -9.53 | -9.38 | -9.26 | -6.06 | -1.67 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.